Changes in cerebral activity after decreased upper-limb hypertonus: An EMG-fMRI study

Magnetic Resonance Imaging

Volumn 28, Issue 5, 2010, Pages 646-652

  Manganotti, Paolo ^a,b   Acler, Michele ^a   Formaggio, Emanuela ^a   Avesani, Mirko ^a   Milanese, Franco ^a   Baraldo, Andrea ^a   Storti, Silvia Francesca ^a   Gasparini, Anna ^a   Cerini, Roberto ^a   Mucelli, Roberto Pozzi ^a   Fiaschi, Antonio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Botulinum toxin; EMG; FMRI; Spasticity; Stroke

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CEREBELLUM; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DYNAMOMETER; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAND GRIP; HAND MUSCLE; HEMIPARESIS; HUMAN; IMAGE ANALYSIS; MALE; MOTOR PERFORMANCE; MUSCLE HYPERTONIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSORIMOTOR CORTEX; SPASTICITY; STROKE; TASK PERFORMANCE; TREATMENT RESPONSE; ARM; BRAIN MAPPING; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; MIDDLE AGED; MOTOR CORTEX; MOVEMENT (PHYSIOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES;

AGED; ARM; BRAIN MAPPING; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR CORTEX; MOVEMENT; MUSCLE HYPERTONIA;

EID: 77952959568     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2009.12.023     Document Type: Article

References (37)

1. Mathers C.D., Loncar D. Projection of global mortality and burden of disease from 2002 to 2030. PLos Med 2006, 3:e442.
2. Watkins C.L., Leathley M.J., Gregson J.M., Moore A.P., Smith T.L., Sharma A.K. Prevalence of spasticity post-stroke. Clin Rehabil 2002, 16:515-522.
3. Simpson D.M., Alexander N., O'Brien C.F., Tagliati M., Aswad A.S., Leon I.M., et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996, 46:1306-1310.
4. Brashear A., Gordon M.F., Elovic E., Kassicieh V.D., Marciniak C., Do M., et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. N Engl J Med 2002, 347:395-400.
5. Hesse S., Werner C. Post-stroke motor dysfunction and spasticity: novel pharmacological and physical treatment strategies. CNS Drugs 2003, 17:1093-1107.
6. Kanovsky P., Streitova H., Dufek J., Znojil V., Daniel P., Rektor I. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A. Mov Disord 1998, 13:108-117.
7. Gilio F., Curra A., Lorenzano C., Modugno N., Manfredi M., Berardelli A. Effects of botulinum toxin Type A on intracortical inhibition in patients with dystonia. Ann Neurol 2000, 48:20-26.
8. Abbruzzese G., Berardelli A. Sensorimotor integration in movement disorders. Mov Disord 2003, 18:231-240.
9. Nudo R.J., Wise B.M., SiFuentes F., Millike G.W. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 1996, 272:1791-1794.
10. Weiller C., Chollet F., Friston K.J., Wise R.J.S., Frackowiak R.S.J. Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 1992, 31:463-472.
11. Cramer S.C., Nelles G., Benson R.R., Kaplan J.D., Parker R.A., Kwong K.K., et al. A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 1997, 28:2518-2527.
12. Marshall R.S., Perera G.M., Lazar R.M., Krakauer J.W., Constantine R.C., DeLaPaz R.L. Evolution of cortical activation during recovery from corticospinal tract infarction. Stroke 2000, 31:656-661.
13. Calautti C., Baron J.C. Functional neuroimaging studies of motor recovery after stroke in adults. Stroke 2003, 34:1553-1566. (Review).
14. Johansen-Berg H., Dawes H., Guy C., Smith S.M., Wade D.T., Matthews P.M. Correlation between motor improvements and altered fMRI activity after rehabilitative therapy. Brain 2002, 125:2731-2742.
15. Ward N.S., Brown M.M., Thompson A.L., Frackowiak R.S. The influence of time after stroke on brain activations during a motor task. Ann Neurol 2004, 6:829-834.
16. Carey J.R., Kimberley T.J., Lewis S.M., Auerbach E.J., Dorsey L., Rundquist P., et al. Analysis of fMRI and finger tracking training in subjects with chronic stroke. Brain 2002, 125:773-788.
17. Nelles G. Cortical reorganization: effects of intensive therapy. Restor Neurol Neurosci 2004, 22:239-244.
18. Brott T., Adams H.P., Olinger C.P., Marler J.R., Barsan W.G., Biller J., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 20:864-870.
19. Bohannon R.W., Smith M.B. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1986, 67:206-207.
20. Demeurisse G., Demol O., Robaye E. Motor evaluation in vascular hemiplegia. Eur Neurol 1980, 19:382-389.
21. Mahoney F.I., Barthel D.W. Functional evaluation: the Barthel Index. Md State Med J 1965, 14:61-85.
22. Friston K.J., Holmes A.P., Poline J.B., et al. Analysis of fMRI time-series revisited. Neuroimage 1995, 2:45-53.
23. Boynton G.M., Engel S.A., Glover G.H., Heeger D.J. Linear systems analysis of functional magnetic resonance imaging in human V1. J Neurosci 1996, 16:4207-4221.
24. Cramer S.C., Nelles G., Schaechter J.D., Kaplan J.D., Finklestein S.P., Rosen B.R. A functional MRI study of three motor tasks in the evaluation of stroke recovery. Neurorehabil Neural Repair 2001, 15:1-8.
25. Currà A., Trompetto C., Abruzzese G., Berardelli A. Central effects of botulinum toxin type A: evidence and supposition. Mov Disord 2004, 19(Suppl. 8):S60-S64. (Review).
26. Girlanda P., Quartarone A., Sinicropi S., Nicolosi C., Roberto M.L., Picciolo G., et al. Botulinum toxin in upper limb spasticity: study of reciprocal inhibition between forearm muscles. Neuroreport 1997, 8:3039-3044.
27. Byrnes M.L., Thickbroom G.W., Wilson S.A., Sacco P., Shipman J.M., Stell R., et al. The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injection. Brain 1998, 121:977-988.
28. Ceballos-Baumann A.O., Sheean G., Passingham R.E., Marsden C.D., Brooks D.J. Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study. Brain 1997, 120:571-582.
29. Calautti C., Naccarato M., Jones P.S., Sharma N., Day D.D., Carpenter A.T., et al. The relationship between motor deficit and hemisphere activation balance after stroke: a 3T fMRI study. Neuroimage 2007, 34:322-331.
30. Manganotti P., Patuzzo S., Cortese F., Palermo A., Smania N., Fiaschi A. Motor disinhibition in affected and unaffected hemisphere in the early period of recovery after stroke. Clin Neurophysiol 2002, 113:936-943.
31. Manganotti P., Acler M., Zanette G.P., Smania N., Fiaschi A. Motor cortical disinhibition during early and late recovery after stroke. Neurorehabil Neural Repair 2008, 22:396-403.
32. Weiller C., Ramsay S.C., Wise R.J., Friston K.J., Frackowiak R.S. Individual patterns of functional reorganization in the human cerebral cortex after capsular infarction. Ann Neurol 1993, 33:181-189.
33. Shamoto H., Chugani H.T. Glucose metabolism in the human cerebellum: an analysis of crossed cerebellar diaschisis in children with unilateral cerebral injury. J Child Neurol 1997, 12:407-414.
34. Baron J.C., Bousser M.G., Comar D., Castaigne P. 'Crossed cerebellar diaschisis' in human supratentorial brain infarction. Trans Am Neurol Assoc 1980, 105:459-461.
35. Ramnani N., Toni I., Josephs O., Ashburner J., Passingham R.E. Learning- and expectation-related changes in the human brain during motor learning. J Neurophysiol 2000, 84:3026-3035.
36. Richardson M.P., Grosse P., Allen P.J., Turner R., Brown P. BOLD correlates of EMG spectral density in cortical myoclonus: description of method and case report. Neuroimage 2006, 32:558-565.
37. Van Duinen H., Zijdewind I., Hoogduin H., Maurits N. Surface EMG measurements during fMRI at 3T: accurate EMG recordings after artifact correction. Neuroimage 2005, 27:240-246.